Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients

This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Case Rep
Asıl Yazarlar: Meeder, Annelijn M, van der Steen, Marijke S, Rozendaal, Annemieke, van Zanten, Arthur R H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/
https://ncbi.nlm.nih.gov/pubmed/27698008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller